Citations

Mayo Clinic

Showing 10 of 108551 citations.

Genome-Wide Association Studies in Primary Biliary Cirrhosis
Gulamhusein, Aliya , Juran, Brian D., Gulamhusein, Aliya F, Lazaridis, Konstantinos N. , Lazaridis, Konstantinos

Seminars in Liver Disease | December 16, 2015 | Volume: 35 | Issue: 04 | Pages: 392-401

10.1055/s-0035-1567831 | PMID 26676814 Get It

Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease
Hart, Steven N. , Halling, Geoffrey C. , Johnson, Sarah H. , Smadbeck, James B. , Drucker, Travis, Lima, Joema Felipe , Rohakhtar, Fariborz Rakhshan, Harris, Faye R. , Kosari, Farhad , Subramanian, Subbaya , Petersen, Gloria M. , Wiltshire, Timothy D. , Kipp, Benjamin R. , Truty, Mark J. , Vasmatzis, George , McWilliams, Robert R. , Murphy, Stephen J. , Couch, Fergus J. , Hart, Steven N

Cancer Research | December 16, 2015 | Volume: 76 | Issue: 3 | Pages: 749-761

10.1158/0008-5472.can-15-2198 | PMID 26676757 Get It

Abstract Many somatic mutations have been detected in pancreatic ductal adenocarcinoma (PDAC), leading to the identification of some key drivers of disease progression, but the involvement of large genomic rearrangements has often been overlooked. In this study, we performed mate pair sequencing (MPseq) on genomic DNA from 24 PDAC tumors, including 15 laser-captured microdissected PDAC and 9 patient-derived xenografts, to identify genome-wide rearrangements. Large genomic rearrangements with intragenic breakpoints altering key regulatory genes involved in PDAC progression were detected in all tumors. SMAD4, ZNF521, and FHIT were among the most frequently hit genes. Conversely, commonly reported genes with copy number gains, including MYC and GATA6, were frequently observed in the absence of direct intragenic breakpoints, suggesting a requirement for sustaining oncogenic function during PDAC progression. Integration of data from MPseq, exome sequencing, and transcriptome analysis of primary PDAC cases identified limited overlap in genes affected by both rearrangements and point mutations. However, significant overlap was observed in major PDAC-associated signaling pathways, with all PDAC exhibiting reduced SMAD4 expression, reduced SMAD-dependent TGFβ signaling, and increased WNT and Hedgehog signaling. The frequent loss of SMAD4 and FHIT due to genomic rearrangements strongly implicates these genes as key drivers of PDAC, thus highlighting the strengths of an integrated genomic and transcriptomic approach for identifying mechanisms underlying disease initiation and progression. Cancer Res; 76(3); 749–61. ©2015 AACR.
HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy
Liu, Tongzheng , Fang, Yuan , Zhang, Haoxing , Deng, Min , Gao, Bowen , Niu, Nifang, Yu, Jia , Lee, SeungBaek, Kim, Jung-Jin, Qin, Bo , Evans, Debra L., Wang, Liewei , Lou, Wenhui, Xie, Fang , Lee, Seung Baek , Kim, JungJin, Evans, Debra, Lee, SeungBaek , Xie, Fang , Lou, Zhenkun , Lee, Seung Baek

Cancer Research | December 16, 2015 | Volume: 76 | Issue: 3 | Pages: 572-581

10.1158/0008-5472.can-15-0671 | PMID 26676747 Get It

Abstract Elucidating mechanisms of chemoresistance is critical to improve cancer therapy, especially for the treatment of pancreatic ductal adenocarcinoma (PDAC). Genome-wide association studies have suggested the less studied gene HEAT repeat-containing protein 1 (HEATR1) as a possible determinant of cellular sensitivity to different chemotherapeutic drugs. In this study, we assessed this hypothesized link in PDAC, where HEATR1 expression is downregulated significantly. HEATR1 silencing in PDAC cells increased resistance to gemcitabine and other chemotherapeutics, where this effect was associated with increased AKT kinase phosphorylation at the Thr308 regulatory site. Mechanistically, HEATR1 enhanced cell responsiveness to gemcitabine by acting as a scaffold to facilitate interactions between AKT and the protein phosphatase PP2A, thereby promoting Thr308 dephosphorylation. Consistent with these findings, treatment with the AKT inhibitor triciribine sensitized HEATR1-depleted PDAC cells to gemcitabine, suggesting that this therapeutic combination may overcome gemcitabine resistance in patients with low HEATR1 expression. Clinically, we found that HEATR1 downregulation in PDAC patients was associated with increased AKT phosphorylation, poor response to tumor resection plus gemcitabine standard-of-care treatment, and shorter overall survival. Collectively, our findings establish HEATR1 as a novel regulator of AKT and a candidate predictive and prognostic indicator of drug responsiveness and outcome in PDAC patients. Cancer Res; 76(3); 572–81. ©2015 AACR.
Pulsatility of Hypothalamo-Pituitary Hormones: A Challenge in Quantification
Keenan, Daniel M., Veldhuis, Johannes D.

Physiology | December 16, 2015 | Volume: 31 | Issue: 1 | Pages: 34-50

10.1152/physiol.00027.2015 | PMID 26674550 Get It

Neuroendocrine systems control many of the most fundamental physiological processes, e.g., reproduction, growth, adaptations to stress, and metabolism. Each such system involves the hypothalamus, the pituitary, and a specific target gland or organ. In the quantification of the interactions among these components, biostatistical modeling has played an important role. In the present article, five key challenges to an understanding of the interactions of these systems are illustrated and discussed critically.
A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1
Lu, Kang , Grande, Joseph P. , Hillestad, Matthew L. , Croatt, Anthony J., Barry, Michael A. , Katušić, Zvonimir S. , Nath, Karl A. , Kang, Lu, Barry, Michael A

American Journal of Physiology-Renal Physiology | December 16, 2015 | Volume: 310 | Issue: 6 | Pages: F466-F476

10.1152/ajprenal.00288.2015 | PMID 26672617 Get It

The arteriovenous fistula (AVF) is the preferred hemodialysis vascular access, but it is complicated by high failure rates and attendant morbidity. This study provides the first description of a murine AVF model that recapitulates two salient features of hemodialysis AVFs, namely, anastomosis of end-vein to side-artery to create the AVF and the presence of chronic kidney disease (CKD). CKD reduced AVF blood flow, observed as early as 3 days after AVF creation, and increased neointimal hyperplasia, venous wall thickness, thrombus formation, and vasculopathic gene expression in the AVF. These adverse effects of CKD could not be ascribed to preexisting alterations in blood pressure or vascular reactivity in this CKD model. In addition to vasculopathic genes, CKD induced potentially vasoprotective genes in the AVF such as heme oxygenase-1 (HO-1) and HO-2. To determine whether prior HO-1 upregulation may protect in this model, we upregulated HO-1 by adeno-associated viral gene delivery, achieving marked venous induction of the HO-1 protein and HO activity. Such HO-1 upregulation improved AVF blood flow and decreased venous wall thickness in the AVF. Finally, we demonstrate that the administration of carbon monoxide, a product of HO, acutely increased AVF blood flow. This study thus demonstrates: 1) the feasibility of a clinically relevant murine AVF model created in the presence of CKD and involving an end-vein to side-artery anastomosis; 2) the exacerbatory effect of CKD on clinically relevant features of this model; and 3) the beneficial effects in this model conferred by HO-1 upregulation by adeno-associated viral gene delivery.
Muscle movement and loss
Lanza, Ian R. , Lanza, Ian R

Science Translational Medicine | December 16, 2015 | Volume: 7 | Issue: 318 | Pages: No page available

10.1126/scitranslmed.aad9006 Get It

Immobilization causes loss of muscle by decreasing its protein synthesis and response to feeding.
MRI-Guided Stereotactic System for Delivery of Intraspinal Microstimulation
Grahn, Peter J. , Goerss, Stephan J., Mallory, Grant W., Kall, Bruce A., Mendez, Aldo A. , Trevathan, James K. , Felmlee, Joel P. , Bennet, Kevin E. , Lee, Kendall H. , Luján, J. Luis , Trevathan, James K

Spine | December 16, 2015 | Volume: 41 | Issue: 13 | Pages: E806-E813

10.1097/brs.0000000000001397 | PMID 26679880 Get It

Study Design. Laboratory/animal-based proof of principle study. Objective. To validate the accuracy of a magnetic resonance imaging (MRI)-guided stereotactic system for intraspinal electrode targeting and demonstrate the feasibility of such a system for controlling implantation of intraspinal electrodes. Summary of Background Data. Intraspinal microstimulation (ISMS) is an emerging preclinical therapy, which has shown promise for the restoration of motor function following spinal cord injury. However, targeting inaccuracy associated with existing electrode implantation techniques remains a major barrier preventing clinical translation of ISMS. Methods. System accuracy was evaluated using a test phantom comprised of nine target locations. Targeting accuracy was determined by calculating the root mean square error between MRI-generated coordinates and actual frame coordinates required to reach the target positions. System performance was further validated in an anesthetized pig model by performing MRI-guided intraspinal electrode implantation and stimulation followed by computed tomography of electrode location. Finally, system compatibility with a commercially available microelectrode array was demonstrated by implanting the array and applying a selection of stimulation amplitudes that evoked hind limb responses. Results. The root mean square error between actual frame coordinates and software coordinates, both acquired using the test phantom, was 1.09 ± 0.20 mm. Postoperative computed tomography in the anesthetized pig confirmed spatially accurate electrode placement relative to preoperative MRI. Additionally, MRI-guided delivery of a microwire electrode followed by ISMS evoked repeatable electromyography responses in the biceps femoris muscle. Finally, delivery of a microelectrode array produced repeatable and graded hind limb evoked movements. Conclusion. We present a novel frame-based stereotactic system for targeting and delivery of intraspinal instrumentation. This system utilizes MRI guidance to account for variations in anatomy between subjects, thereby improving upon existing ISMS electrode implantation techniques. Level of Evidence: N/A
Investigation of the effects of myocardial anisotropy for shear wave elastography using impulsive force and harmonic vibration
Qiang, Bo, Song, Pengfei , Nenadic, Ivan , Chen, Shigao , Greenleaf, James F. , Urban, Matthew W. , Nenadic, Ivan Z, Song, Pengfei

Physics in Medicine & Biology | December 16, 2015 | Volume: 61 | Issue: 1 | Pages: 365-382

10.1088/0031-9155/61/1/365 | PMID 26674613 Get It

Abstract The myocardium is known to be an anisotropic medium where the muscle fiber orientation changes through the thickness of the wall. Shear wave elastography methods use propagating waves which are measured by ultrasound or magnetic resonance imaging (MRI) techniques to characterize the mechanical properties of various tissues. Ultrasound- or MR-based methods have been used and the excitation frequency ranges for these various methods cover a large range from 24–500 Hz. Some of the ultrasound-based methods have been shown to be able to estimate the fiber direction. We constructed a model with layers of elastic, transversely isotropic materials that were oriented at different angles to simulate the heart wall in systole and diastole. We investigated the effect of frequency on the wave propagation and the estimation of fiber direction and wave speeds in the different layers of the assembled models. We found that waves propagating at low frequencies such as 30 or 50 Hz showed low sensitivity to the fiber direction but also had substantial bias in estimating the wave speeds in the layers. Using waves with higher frequency content (>200 Hz) allowed for more accurate fiber direction and wave speed estimation. These results have particular relevance for MR- and ultrasound-based elastography applications in the heart.
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry
Molho, Eric , Stacy, Mark, Gillard, Patrick, Charles, David , Schwartz, Marc , Brin, Mitchell F. , Adler, Charles H. , Jankovic, Joseph J.

Movement Disorders Clinical Practice | December 16, 2015 | Volume: 3 | Issue: 2 | Pages: 130-138

10.1002/mdc3.12238 | PMID 27774495 Get It

Abstract Background Cervical dystonia is thought to result in high disease burden, but limited information exists on its impact on employment and work productivity. We utilized data from the Cervical Dystonia Patient Registry for the Observation of OnabotulinumtoxinA Efficacy (ClinicalTrials.gov identifier: NCT 00836017) to assess the impact of cervical dystonia on employment and work productivity and examine the effect of onabotulinumtoxinA treatments on work productivity. Methods Subjects completed a questionnaire on employment status and work productivity at baseline and final visit. Baseline data were examined by severity of cervical dystonia, predominant subtype, presence of pain, prior exposure to botulinum toxin, and/or utility of a sensory trick. Work productivity results at baseline and final visit were compared in subjects who were toxin‐naïve at baseline and received three onabotulinumtoxinA treatments. Results Of 1,038 subjects, 42.8% were employed full‐ or part‐time, 6.1% unemployed, 32.7% retired, and 11.8% disabled. Of those currently employed, cervical dystonia affected work status of 26.0%, caused 29.8% to miss work in the past month (mean, 5.1 ± 6.4 days), and 57.8% reported decreased productivity. Half of those unemployed were employed when symptoms began, and 38.5% attributed lost employment to cervical dystonia. Pain, increasing severity, and anterocollis/retrocollis had the largest effects on work status/productivity. Preliminary analyses showed that absenteeism and presenteeism were significantly decreased following onabotulinumtoxinA treatments in the subpopulation that was toxin‐naïve at baseline. Conclusions This analysis confirms the substantial negative impact of cervical dystonia on employment, with cervical dystonia‐associated pain being a particularly important driver. OnabotulinumtoxinA treatment appears to improve work productivity.
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke
Ungprasert, Patompong , Matteson, Eric L. , Thongprayoon, Charat

Stroke | December 16, 2015 | Volume: 47 | Issue: 2 | Pages: 356-364

10.1161/strokeaha.115.011678 | PMID 26670086 Get It

Background and Purpose— The association between hemorrhagic stroke and use of nonsteroidal anti-inflammatory drugs (NSAIDs) is not well established. We conducted a systematic review and meta-analysis of observation studies to further characterize this possible association. Methods— Case–control and cohort studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing risk of hemorrhagic stroke among NSAIDs users versus nonusers were systematically searched. Point estimates from each study were extracted. Pooled risk ratios (RR) and 95% confidence intervals (CI) for all NSAIDs and individual NSAIDs were calculated using random-effect, generic inverse variance method. Results— Ten studies were identified and included in our data analysis. As a single group, NSAIDs use was associated with a small but insignificant risk of hemorrhagic stroke with the pooled RR of 1.09 (95% CI, 0.98–1.22). Individual NSAIDs analysis revealed a significantly increased risk among diclofenac and meloxicam users (RR 1.27; 95% CI, 1.02–1.59 and RR 1.27; 95% CI, 1.08–1.50, respectively). The risk estimate for rofecoxib users was higher, but statistically nonsignificant (RR 1.35; 95% CI, 0.88–2.06). Conclusions— Overall, the use of NSAIDs is not associated with an increased risk of hemorrhagic stroke, although this risk was modestly significantly elevated in diclofenac and meloxicam users.